The overexpression of Tim3 on hematopoietic stem cells in myelodysplastic syndrome (MDS) is associated with malignant biological characteristics that make it abnormal differentiation and excessive proliferation, so Tim3 may be the marker for identifying malignant clonal cells or potential therapeutic targets for MDS (22). The gene discussed is HAVCR2; the disease is myelodysplastic syndrome.